Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar

Christel Deskins

WINNIPEG, AB, Oct. 5, 2020 /CNW/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, announces that through its wholly-owned subsidiary, Medicure International Inc., it has entered into a License, Manufacture and Supply Agreement (the “Agreement”) with Reliance Life Sciences Private Limited (“RLS”) for a cardiovascular […]